源语言 | 英语 |
---|---|
页(从-至) | 161-169 |
页数 | 9 |
期刊 | The Lancet |
卷 | 400 |
期 | 10347 |
DOI | |
出版状态 | 已出版 - 7月 16 2022 |
!!!ASJC Scopus Subject Areas
- 一般医学
指纹
探究 'Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial' 的科研主题。它们共同构成独一无二的指纹。引用此
(编辑) (2022). Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. The Lancet, 400(10347), 161-169. https://doi.org/10.1016/S0140-6736(22)01054-6